SBI Securities’s NewGenIvf NIVF Stock Holding History

SBI Securities’s Portfolio NIVF Stock Details NIVF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62	Buy	+3	New	+$139	﹤0.01%	3626
2026 Q1	–	Hold	0	–	–	–	3846
2025 Q4	–	Hold	0	–	–	–	3609
2025 Q3	–	Hold	0	–	–	–	2926
2025 Q2	–	Hold	0	–	–	–	4018
2025 Q1	–	Hold	0	–	-$406	–	4216
2024 Q4	–	Hold	0	–	–	–	2971

Other funds holding NIVF

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

SBI Securities's NIVF Position: Q2 2026 in Review

SBI Securities opened a new position in NewGenIvf (NIVF) in Q2 2026: 3 shares worth $62. The stake represents ﹤0.01% of the portfolio and ranks #3626 among its holdings.

5 funds tracked by Wall St. Rank hold NIVF as of Q2 2026.

SBI Securities held 3 shares of NewGenIvf worth $62 as of Q2 2026.
NewGenIvf was a new SBI Securities position in Q2 2026.
NewGenIvf made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3626 holding.
5 funds tracked by Wall St. Rank held NewGenIvf as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.